BU-NOT-SET CONTACT US All20252024202320222021 May 13 2025 Recipharm and PLG announce strategic partnership to accelerate development projects May 08 2025 NewBiologix licenses Xcell-Eng-HEK293 cell line to ReciBioPharm for development and manufacture of Adeno-Associated Virus (AAV) therapeutics April 09 2025 Recipharm exceeds sustainability goals with major milestones March 14 2025 Recipharm reports record 2024 revenue and strategic milestones February 27 2025 Recipharm further expands product development capabilities with new pilot scale development February 05 2025 Recipharm expands aseptic filling capabilities for process development, pilot scale and clinical supply January 22 2025 Spektus Pharma and Recipharm Announce Strategic Partnership to Develop and Supply CNS Medicines Using Flexitab™ Oral Drug Delivery Platform January 13 2025 ReciBioPharm secures a significant grant to advance RNA manufacturing November 19 2024 Recipharm's full range Oral Solid Dosage (OSD) capabilities meet growing industry demands October 03 2024 Recipharm strengthens pharmaceutical development capabilities with strategic investments Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Last page
